Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Morabito · SciRah

Researcher profile · Semantic Scholar

A. Morabito

Share profile

A. Morabito — researcher profile on SciRah

h-index: 20
Works: 66
Citations: 1,439

Most-cited papers

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production
Stefania Laurent, P. Queirolo, S. Boero, S. Salvi +14 more
2013Journal of Translational Medicine165 citations Open access
Semantic Scholar
MicroRNA in Glioblastoma: An Overview
B. Banelli, Alessandra Forlani, G. Allemanni, A. Morabito +2 more
2017International Journal of Genomics154 citations Open access
Semantic Scholar
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
S. Salvi, V. Fontana, S. Boccardo, D. E. Merlo +10 more
2012Cancer Immunology and Immunotherapy128 citations
Semantic Scholar
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.
Stefania Laurent, P. Carrega, D. Saverino, P. Piccioli +9 more
2010Human Immunology113 citations
Semantic Scholar
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
M. Pistillo, V. Fontana, A. Morabito, B. Dozin +24 more
2018Cancer Immunology and Immunotherapy82 citations Open access
Semantic Scholar
Immune Checkpoints and Innovative Therapies in Glioblastoma
M. Romani, M. Pistillo, R. Carosio, A. Morabito +1 more
2018Frontiers in Oncology82 citations Open access
Semantic Scholar
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
G. Banna, A. Cortellini, D. Cortinovis, M. Tiseo +42 more
2021ESMO Open61 citations Open access
Semantic Scholar
Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
P. Queirolo, A. Morabito, Stefania Laurent, S. Lastraioli +8 more
2013Cancer Investigation58 citations
Semantic Scholar
HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.
G. Palmisano, Elisabetta Contardi, A. Morabito, Vittoria Gargaglione +2 more
2005Human Immunology53 citations
Semantic Scholar
Association of −318 C/T and +49 A/G cytotoxic T lymphocyte antigen‐4 (CTLA‐4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis
Giuseppe Balbi, F. Ferrera, Marta Rizzi, P. Piccioli +11 more
2007Clinical and Experimental Immunology52 citations Open access
Semantic Scholar
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
S. Boero, A. Morabito, B. Banelli, B. Cardinali +13 more
2015Journal of Translational Medicine49 citations Open access
Semantic Scholar
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
P. Queirolo, B. Dozin, A. Morabito, B. Banelli +27 more
2017Frontiers in Immunology43 citations Open access
Semantic Scholar
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor
S. Roncella, Stefania Laurent, V. Fontana, P. Ferro +18 more
2016Cancer Immunology and Immunotherapy43 citations Open access
Semantic Scholar
CTLA‐4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis
Stefania Laurent, G. Palmisano, A. Martelli, T. Kato +11 more
2007British Journal of Haematology40 citations Open access
Semantic Scholar
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
M. Pistillo, R. Carosio, B. Banelli, A. Morabito +6 more
2019Cellular & Molecular Immunology32 citations Open access
Semantic Scholar
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab.
M. Pistillo, R. Carosio, F. Grillo, V. Fontana +11 more
2020Clinical Immunology26 citations
Semantic Scholar
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab.
P. Queirolo, B. Dozin, A. Morabito, B. Banelli +22 more
2018European Journal of Cancer25 citations
Semantic Scholar
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
L. Mastracci, V. Fontana, P. Queirolo, R. Carosio +12 more
2020Cancer Immunology and Immunotherapy22 citations
Semantic Scholar
Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.
Enrico Battolla, P. Canessa, P. Ferro, Maria Cristiana Franceschini +7 more
2017Anticancer Research22 citations Open access
Semantic Scholar
CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence
P. Piccioli, Giuseppe Balbi, M. Serra, A. Morabito +9 more
2010Annals of Hematology22 citations
Semantic Scholar
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
A. Camerini, A. Morabito, A. Montanino, R. Bernabé +11 more
2021ESMO Open18 citations Open access
Semantic Scholar
Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma.
P. Ferro, P. Canessa, Enrico Battolla, P. Dessanti +8 more
2013Anticancer Research15 citations
Semantic Scholar
HLA-C sequence based typing: nucleotide analysis from exon 1 through exon 8. Identification of a new allele: Cw*0718.
L. Delfino, A. Morabito, G. Ferrara
2003Tissue Antigens13 citations
Semantic Scholar
1222OA RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF AFATINIB (A) VS ERLOTINIB (E) AS SECOND-LINE TREATMENT OF PATIENTS (PTS) WITH ADVANCED SQUAMOUS CELL CARCINOMA (SCC) OF THE LUNG FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY: LUX-LUNG 8 (LL8).
G. Goss, E. Felip, M. Cobo, S. Lu +14 more
2014Annals of Oncology12 citations Open access
Semantic Scholar
Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
A. Morabito, B. Dozin, S. Salvi, G. Pasciucco +8 more
2009Human Immunology12 citations
Semantic Scholar
Hexaprimer amplification refractory mutation system PCR for simultaneous single-tube genotyping of 2 close polymorphisms.
P. Piccioli, M. Serra, S. Pedemonte, Giuseppe Balbi +10 more
2008Clinical Chemistry11 citations Open access
Semantic Scholar
HLA-A, -B, -Cw, -DPB1, -DQA1, -DQB1 and -DRB1 alleles in a population from North Italy
G. Ferrara, L. Delfino, A. Longo, A. Morabito +1 more
200410 citations
Semantic Scholar
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors
A. Boutros, R. Carosio, Dalila Campanella, F. Spagnolo +10 more
2023Immuno-Oncology Technology9 citations Open access
Semantic Scholar
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.
A. Amaro, Federica Parodi, K. Diedrich, G. Angelini +21 more
2016JAMA ophthalmology9 citations Open access
Semantic Scholar
Single agent vs combination chemotherapy (CT) as second-line treatment of advanced non-small-cell lung cancer (NSCLC): A meta-analysis of individual data of five randomized trials
M. di Maio, P. Chiodini, V. Georgoulias, D. Hatzidaki +6 more
20089 citations
Semantic Scholar
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis
R. Carosio, V. Fontana, L. Mastracci, P. Ferro +10 more
2020Journal of Cancer Research and Clinical Oncology7 citations Open access
Semantic Scholar
A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
B. Banelli, A. Morabito, Stefania Laurent, P. Piccioli +9 more
2014Human Immunology7 citations
Semantic Scholar
HLA-A, -B, -Cw, -DPB1, -DQA1, -DQB1 and -DRB1 allele frequencies in a population from Bergamo, Italy
G. Ferrara, L. Delfino, A. Longo, A. Morabito +1 more
20047 citations
Semantic Scholar
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.
F. Nuzzo, C. Gallo, S. Lastoria, M. di Maio +27 more
20126 citations Open access
Semantic Scholar
Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial
S. Cascinu, R. Berardi, R. Bianco, D. Bilancia +16 more
2019Annals of Oncology4 citations Open access
Semantic Scholar
Analysis of CTLA-4 gene polymorphisms in patients with advanced melanoma treated with anti-CTLA-4 therapy.
P. Queirolo, A. Morabito, P. Piccioli, S. Lastraioli +6 more
2011Journal of Clinical Oncology4 citations
Semantic Scholar
Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial.
R. Califano, M. Hochmair, C. Gridelli, A. Delmonte +11 more
2019Annals of Oncology3 citations Open access
Semantic Scholar
Crizotinib in ROS1 rearranged or MET deregulated non-small-cell lung cancer (NSCLC): final results of the METROS trial.
L. Landi, R. Chiari, C. Dazzi, M. Tiseo +17 more
2016Annals of Oncology3 citations Open access
Semantic Scholar
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
P. Queirolo, B. Dozin, A. Morabito, B. Banelli +27 more
2018Frontiers in Immunology2 citations Open access
Semantic Scholar
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
S. Boero, A. Morabito, B. Banelli, B. Cardinali +13 more
2016Journal of Translational Medicine2 citations Open access
Semantic Scholar
Endocrine effects of adjuvant letrozole versus tamoxifen in hormone responsive postmenopausal early breast cancer patients: results from the HOBOE randomized trial.
A. Morabito, E. Rossi, F. Di Rella, G. Esposito +13 more
20092 citations
Semantic Scholar
HLA class I sequence-based typing for high resolution matching in bone marrow transplantation.
L. Delfino, A. Longo, A. Morabito, A. Parodi +3 more
1999Journal of Biological Regulators and Homeostatic Agents2 citations
Semantic Scholar
1365PEffect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies
M. Piccirillo, A. Morabito, P. Maione, A. Luciani +16 more
20171 citations Open access
Semantic Scholar
1480OSYMPTOMATIC TOXICITIES EXPERIENCED DURING ANTI-CANCER TREATMENT: COMPARISON OF PATIENTS' AND PHYSICIANS' REPORTING IN THREE RANDOMIZED CONTROLLED TRIALS (RCTS).
M. di Maio, M. Piccirillo, G. Daniele, F. Nuzzo +15 more
2014Annals of Oncology1 citations Open access
Semantic Scholar
Education level as prognostic factor of patients (pts) with advanced non-small cell lung cancer (NSCLC) enrolled in clinical trials.
M. di Maio, A. Morabito, S. Barbera, V. Gebbia +6 more
20101 citations
Semantic Scholar
8104 POSTER Expanding the role of the clinical research nurse in an Italian cooperative oncology research group
J. Bryce, M. Catapano, M. Falanga, M. Connola +6 more
20071 citations
Semantic Scholar
P553 - HLA-DQB1*0202 is associated with DRB1*0701
C. Pera, S. Castello, A. Morabito, L. Delfino +1 more
19961 citations
Semantic Scholar
The biology of uveal melanoma – next challenges
F. Reggiani, M. Ambrosio, Alessandra Forlani, A. Morabito +2 more
2022Diagnostics and Therapeutics0 citations Open access
Semantic Scholar
Impact of ErbB Mutations on Clinical Outcomes in Afatinib‐ or Erlotinib‐Treated Patients with SCC of the Lung: P13
G. Goss, M. Cobo, S. Lu, K. Syrigos +13 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
S. Boero, A. Morabito, B. Banelli, B. Cardinali +13 more
2016Journal of Translational Medicine0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Pistillo×30
Invite
M. Pistillo — researcher profile on SciRah
B. Banelli×15
Invite
B. Banelli — researcher profile on SciRah
B. Dozin×14
Invite
B. Dozin — researcher profile on SciRah
Stefania Laurent×13
Invite
Stefania Laurent — researcher profile on SciRah

×13

Invite

P. Piccioli — researcher profile on SciRah

Invite

V. Fontana — researcher profile on SciRah

Invite

R. Carosio — researcher profile on SciRah

Invite

M. Romani — researcher profile on SciRah

Invite

P. Queirolo — researcher profile on SciRah

Invite

S. Salvi — researcher profile on SciRah

Invite

A. Poggi — researcher profile on SciRah

Invite

F. Spagnolo — researcher profile on SciRah